Views & Analysis Innovation and collaboration: key catalysts for scientific b... During my time at Illumina I had a realisation: restricted access to data, and an industry-wide aversion to collaboration, was delaying and in some instances preventing the discovery of tre
Articles Fixing the problems in bioinformatics Data management and analysis is increasingly important as the speed of genome sequencing increases and costs reduce.
Articles Genome project puts England at cutting edge of precision med... A bold initiative aimed at making the NHS a world leader in 'precision medicine', England's 100K Genomes Project is advancing rapidly.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
